Proof of Usefulness Report

Radloff Clinical Evidence Consulting

Analysis completed on 2/14/2026

+53
Proof of Usefulness Score
You're In Business

The project is a niche consulting firm led by a founder with a verified successful exit (Curedatis sold to Research Solutions, NASDAQ: RSSS). While the founder's expertise in Medical Device Regulation (MDR) is high and market timing is strong, the submission quality is extremely poor (claiming audience is 'everyone' and 'most people' have used the product). The score reflects the high credibility of the founder's track record balanced against the unscalable nature of a consulting service and the hyperbolic, low-effort submission.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+16.0
Audience Reach Impact+2.0
Technical Innovation+3.6
Evidence Of Traction+18.75
Market Timing Relevance+7.2
Functional Completeness+0.25
Subtotal+47.8
Usefulness Multiplierx1.11
Final Score+53

Project Details

Description
Supporting medical device, in vitro diagnostic and digital health companies to generate meaningful scientific evidence for superior regulatory compliance. Former: Radloff Clinical Evidence Consulting | CLEVRR sold Curedatis to Research Solution Inc. NASDAQ RSSS

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline